NYSE:OMI - Owens & Minor Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $35.44
  • Forecasted Upside: -15.35 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$41.87
▼ -2.4 (-5.42%)

This chart shows the closing price for OMI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Owens & Minor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OMI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OMI

Analyst Price Target is $35.44
▼ -15.35% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Owens & Minor in the last 3 months. The average price target is $35.44, with a high forecast of $55.00 and a low forecast of $12.00. The average price target represents a -15.35% upside from the last price of $41.87.

This chart shows the closing price for OMI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 9 contributing investment analysts is to hold stock in Owens & Minor. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/31/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/27/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price TargetNeutral$39.00 ➝ $46.00Medium
5/27/2021Robert W. BairdBoost Price TargetBuy ➝ Outperform$52.00 ➝ $55.00Medium
5/27/2021CitigroupBoost Price TargetNeutral$39.00 ➝ $46.00Medium
5/11/2021Credit Suisse GroupBoost Price TargetNeutral$34.00 ➝ $38.00Medium
3/26/2021Robert W. BairdUpgradeOutperform$45.00 ➝ $50.00High
2/25/2021BarclaysBoost Price TargetEqual Weight$23.00 ➝ $33.00High
12/17/2020UBS GroupUpgradeNeutral ➝ Buy$27.00 ➝ $37.00Medium
12/11/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageNeutral$30.00Medium
12/11/2020Smith Barney CitigroupInitiated CoverageNeutral$30.00Low
11/5/2020UBS GroupBoost Price TargetNeutral$13.00 ➝ $27.00High
11/4/2020BarclaysBoost Price TargetEqual Weight$20.00 ➝ $23.00High
9/25/2020CSFBBoost Price TargetNeutral$18.00 ➝ $22.00Low
9/25/2020Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $22.00Medium
9/25/2020BarclaysUpgradeUnderweight ➝ Equal Weight$20.00Low
9/24/2020Robert W. BairdBoost Price TargetOutperform$21.00 ➝ $34.00High
8/7/2020Credit Suisse GroupLower Price TargetNeutral$17.00 ➝ $16.00Low
7/22/2020BarclaysBoost Price TargetUnderweight$4.00 ➝ $10.00High
7/21/2020Robert W. BairdUpgradeNeutral ➝ Outperform$8.00 ➝ $14.00High
7/21/2020Bank of AmericaUpgradeNeutral ➝ Buy$8.00 ➝ $12.00High
6/10/2020CfraBoost Price TargetBuy$8.50 ➝ $9.50High
5/7/2020CfraLower Price TargetBuy$11.00 ➝ $8.50Low
5/5/2020Robert W. BairdDowngradeOutperform ➝ Neutral$8.00High
4/22/2020Credit Suisse GroupInitiated CoverageNeutral$8.00Low
3/30/2020CfraUpgradeHold ➝ Buy$5.50 ➝ $9.00High
1/21/2020Robert W. BairdUpgradeNeutral ➝ Outperform$9.00High
9/6/2019Bank of AmericaBoost Price TargetNeutral$4.00 ➝ $7.50Medium
4/10/2019Bank of AmericaReiterated RatingNeutral$7.00 ➝ $4.50High
2/21/2019BarclaysReiterated RatingSell$5.00Medium
2/21/2019Jefferies Financial GroupReiterated RatingHold$7.00Low
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$8.00High
1/6/2019BarclaysReiterated RatingSell$6.00Low
1/3/2019Bank of AmericaLower Price TargetNeutral ➝ Neutral$11.00 ➝ $7.00Medium
11/2/2018Jefferies Financial GroupReiterated RatingHold$8.50High
11/1/2018BarclaysReiterated RatingUnderweight ➝ Underweight$12.00 ➝ $8.00High
10/31/2018SVB LeerinkSet Price TargetHold$9.00High
10/31/2018Bank of AmericaDowngradeBuy ➝ NeutralHigh
3/8/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$16.00Medium
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$19.00Low
2/15/2018JPMorgan Chase & Co.Lower Price TargetUnderweight ➝ Underweight$21.00 ➝ $20.00Low
12/19/2017JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$22.00High
11/20/2017Credit Suisse GroupReiterated RatingUnderperform$31.00 ➝ $17.00N/A
11/2/2017SVB LeerinkReiterated RatingMarket Perform$34.00 ➝ $23.00N/A
10/12/2017Robert W. BairdReiterated RatingHold$28.00N/A
9/1/2017Robert W. BairdUpgradeUnderperform ➝ Neutral$28.00Medium
8/9/2017Jefferies Financial GroupReiterated RatingHold$36.00 ➝ $32.00Low
8/9/2017UBS GroupReiterated RatingSell$30.50 ➝ $29.50Medium
8/3/2017UBS GroupReiterated RatingSell$30.50 ➝ $29.50Medium
7/7/2017Jefferies Financial GroupReiterated RatingHold$36.00Low
5/22/2017Jefferies Financial GroupSet Price TargetHold$36.00Low
4/21/2017Jefferies Financial GroupReiterated RatingHold$36.00Low
3/16/2017Jefferies Financial GroupSet Price TargetHold$36.00Medium
11/7/2016Bank of AmericaDowngradeNeutral ➝ Underperform$32.00N/A
10/5/2016UBS GroupInitiated CoverageSell$31.50N/A
9/12/2016Bank of AmericaInitiated CoverageNeutralN/A
(Data available from 6/23/2016 forward)
Owens & Minor logo
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.
Read More

Today's Range

Now: $41.87
Low: $41.68
High: $43.92

50 Day Range

MA: $38.99
Low: $30.73
High: $48.72

52 Week Range

Now: $41.87
Low: $7.00
High: $49.16

Volume

1,335,425 shs

Average Volume

1,279,312 shs

Market Capitalization

$3.15 billion

P/E Ratio

27.01

Dividend Yield

0.02%

Beta

0.23

Frequently Asked Questions

What sell-side analysts currently cover shares of Owens & Minor?

The following Wall Street analysts have issued research reports on Owens & Minor in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, CSFB, Robert W. Baird, Smith Barney Citigroup, TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for OMI.

What is the current price target for Owens & Minor?

9 Wall Street analysts have set twelve-month price targets for Owens & Minor in the last year. Their average twelve-month price target is $35.44, suggesting a possible downside of 15.3%. Robert W. Baird has the highest price target set, predicting OMI will reach $55.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $12.00 for Owens & Minor in the next year.
View the latest price targets for OMI.

What is the current consensus analyst rating for Owens & Minor?

Owens & Minor currently has 6 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OMI, but not buy more shares or sell existing shares.
View the latest ratings for OMI.

What other companies compete with Owens & Minor?

Other companies that are similar to Owens & Minor include McKesson, AmerisourceBergen, Cardinal Health, Henry Schein and Patterson Companies.

How do I contact Owens & Minor's investor relations team?

Owens & Minor's physical mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company's listed phone number is 804-723-7000 and its investor relations email address is [email protected] The official website for Owens & Minor is www.owens-minor.com.